Updated
Updated · CNBC · Aug 10
Cramer's Trust Buys 100 Intel Shares as $15 Billion Stock Sale Hits AI Bet
Updated
Updated · CNBC · Aug 10

Cramer's Trust Buys 100 Intel Shares as $15 Billion Stock Sale Hits AI Bet

3 articles · Updated · CNBC · Aug 10

Summary

  • At about $97.98, Jim Cramer's Charitable Trust bought 100 Intel shares, lifting its stake to 1,400 shares and portfolio weighting to 3.3% from 3.1%.
  • Intel stock fell roughly 4% after the chipmaker announced a $15 billion equity sale, with an option for another $2.25 billion, diluting existing shareholders.
  • Management had already signaled it might tap capital markets as capex rises above $20 billion this year and 2027 spending is expected to run significantly above 2026 levels.
  • Intel said customer demand tied to AI compute is driving the timing, citing opportunities in physical AI, purpose-built silicon, advanced packaging and external wafers.
  • The trust is treating the offering as a manageable overhang and a way for Intel to fund foundry expansion and next-generation manufacturing from a position of relative strength.

Insights

Will Intel’s massive $20 billion stock dilution trap investors, or is it the ultimate catalyst for its AI-driven foundry dominance?
Behind the upbeat earnings, is Intel’s massive capital raise a brilliant strategic play or a desperate bid to fund its 14A survival?
Can Intel's high-stakes gamble on advanced packaging and 2027 fabs truly dethrone its rivals in the relentless AI hardware race?